Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway

Jin,Xin; Fu,Wan; Zhou,Jiaxiu; Shuai,Niannian; Yang,Yan; Wang,Bo

doi:10.3892/ijmm.2021.5020

Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway

Authors:
- Xin Jin
- Wan Fu
- Jiaxiu Zhou
- Niannian Shuai
- Yan Yang
- Bo Wang
View Affiliations

Affiliations: Department of Anesthesiology, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Neurology, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Anesthesiology, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China
Published online on: August 4, 2021 https://doi.org/10.3892/ijmm.2021.5020
Article Number: 187
Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxymatrine, a quinolizidine alkaloid isolated from the traditional Chinese herb Sophora flavescens Aiton, has been demonstrated to exert anti‑inflammatory and atherosclerotic effects, but the molecular mechanism has yet to be elucidated. Accumulating evidence indicates an important role of NLR family pyrin domain containing 3 (NLRP3) inflammasome‑mediated pyroptosis in the pathogenesis of atherosclerosis. The present study was undertaken to investigate whether oxymatrine attenuates oxidized low‑density lipoprotein (ox‑LDL)‑induced human umbilical vein endothelial cell (HUVEC) injury, an in vitro cell model of atherosclerosis, by inhibiting NLRP3 inflammasome‑mediated pyroptosis, and elucidate the role of the sirtuin (SIRT)1/nuclear factor‑erythroid 2‑related factor 2 (Nrf2) signaling pathway in this process. Cell viability and cytotoxicity were detected by CCK‑8 assay and a lactate dehydrogenase (LDH) assay kit. Cell apoptosis was detected by flow cytometry. Reactive oxygen species (ROS) generation was detected using a ROS assay kit. The malondialdehyde (MDA) content, mitochondrial membrane potential (MMP) level, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH‑Px) activities were determined using commercial kits. The inflammatory cytokines levels were measured by ELISA and protein expression was monitored by western blot analysis. The results revealed that oxymatrine alleviated ox‑LDL‑induced cytotoxicity and apoptosis. Concurrently, oxymatrine inhibited ox‑LDL‑induced NLRP3 inflammasome‑mediated pyroptosis in HUVECs, as evidenced by the significant decreases in the expression of NLRP3, apoptosis‑associated speck‑like protein containing a C‑terminal caspase recruitment domain (ASC), cleaved caspase‑1, interleukin (IL)‑1β and IL‑18 in HUVECs. In addition, NLRP3 siRNA transfection efficiently suppressed ox‑LDL‑induced pyroptosis and HUVEC injury. Furthermore, oxymatrine promoted SIRT1/Nrf2 signaling pathway activation in HUVECs subjected to ox‑LDL treatment, and SIRT1 deficiency induced by SIRT1 siRNA transfection abolished the protective effect of oxymatrine against ox‑LDL‑induced injury. SIRT1 siRNA also mitigated the oxymatrine‑induced decreases in ROS generation and MDA content, and the increases in MMP as well as the activities of SOD, CAT and GSH‑Px in HUVECs. Moreover, SIRT1 siRNA transfection blocked the inhibitory effect of oxymatrine on NLRP3 inflammasome‑mediated pyroptosis in ox‑LDL‑treated HUVECs. Collectively, these results indicated that oxymatrine may attenuate ox‑LDL‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via activating the SIRT1/Nrf2 signaling pathway.

View Figures

View References

1	Kobiyama K and Ley K: Atherosclerosis. Circ Res. 123:1118–1120. 2018. View Article : Google Scholar
2	Libby P, Bornfeldt KE and Tall AR: Atherosclerosis: Successes, surprises, and future challenges. Circ Res. 118:531–534. 2016. View Article : Google Scholar
3	Baldrighi M, Mallat Z and Li X: NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis. 267:127–138. 2017. View Article : Google Scholar : PubMed/NCBI
4	Paramel Varghese G, Folkersen L, Strawbridge RJ, Halvorsen B, Yndestad A, Ranheim T, Krohg-Sørensen K, Skjelland M, Espevik T, Aukrust P, et al: NLRP3 inflammasome expression and activation in human atherosclerosis. J Am Heart Assoc. 5:e0030312016. View Article : Google Scholar :
5	Jiang C and Jiang L, Li Q, Liu X, Zhang T, Dong L, Liu T, Liu L, Hu G, Sun X and Jiang L: Acrolein induces NLRP3 inflammasome-mediated pyroptosis and suppresses migration via ROS-dependent autophagy in vascular endothelial cells. Toxicology. 410:26–40. 2018. View Article : Google Scholar
6	Qiu Z, Lei S, Zhao B, Wu Y, Su W, Liu M, Meng Q, Zhou B, Leng Y and Xia ZY: NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017:97432802017. View Article : Google Scholar : PubMed/NCBI
7	Sutterwala FS, Haasken S and Cassel SL: Mechanism of NLRP3 inflammasome activation. Ann NY Acad Sci. 1319:82–95. 2014. View Article : Google Scholar
8	Jia C, Zhang J, Chen H, Zhuge Y, Chen H, Qian F, Zhou K, Niu C, Wang F, Qiu H, et al: Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation. Cell Death Dis. 10:7782019. View Article : Google Scholar
9	Li P, Zhong X, Li J, Liu H, Ma X, He R and Zhao Y: MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis. Biochem Biophys Res Commun. 503:2833–2840. 2018. View Article : Google Scholar : PubMed/NCBI
10	Zahid A, Li B, Kombe AJK, Jin T and Tao J: Pharmacological Inhibitors of the NLRP3 Inflammasome. Front Immunol. 10:25382019. View Article : Google Scholar : PubMed/NCBI
11	Zhang L, Yuan M, Zhang L, Wu B and Sun X: Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis. Biochem Biophys Res Commun. 514:266–272. 2019. View Article : Google Scholar : PubMed/NCBI
12	Liu Y, Wang H, Liu N, Du J, Lan X, Qi X, Zhuang C, Sun T, Li Y and Yu J: Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K/Akt/GSK3β pathway. Life Sci. 254:1164442020. View Article : Google Scholar
13	Liang J, Chang B, Huang M, Huang W, Ma W, Liu Y, Tai W, Long Y and Lu Y: Oxymatrine prevents synovial inflammation and migration via blocking NF-κB activation in rheumatoid fibroblast-like synoviocytes. Int Immunopharmacol. 55:105–111. 2018. View Article : Google Scholar
14	Zhang YY, Yi M and Huang YP: Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats. Cell Physiol Biochem. 43:626–635. 2017. View Article : Google Scholar : PubMed/NCBI
15	Hu ST, Tang Y, Shen YF, Ao HH, Bai J, Wang YL and Yang YJ: Protective effect of oxymatrine on chronic rat heart failure. J Physiol Sci. 61:363–372. 2011. View Article : Google Scholar
16	Yang Y, Chen S, Tao L, Gan S, Luo H, Xu Y and Shen X: Inhibitory effects of oxymatrine on transdifferentiation of neonatal rat cardiac fibroblasts to myofibroblasts induced by aldosterone via Keap1/Nrf2 signaling pathways in vitro. Med Sci Monit. 25:5375–5388. 2019. View Article : Google Scholar
17	Huang XY and Chen CX: Effect of oxymatrine, the active component from Radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats. Phytomedicine. 20:202–212. 2013. View Article : Google Scholar
18	Wu B, Yue H, Zhou GH, Zhu YY, Wu TH, Wen JF, Cho KW and Jin SN: Protective effects of oxymatrine on homocysteine-induced endothelial injury: Involvement of mitochondria-dependent apoptosis and Akt-eNOS-NO signaling pathways. Eur J Pharmacol. 864:1727172019. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y, Zhang Y, Tang J, Zhao S, Li C, Huang YP and Yi M: Oxymatrine inhibits homocysteine-mediated autophagy via MIF/mTOR signaling in human umbilical vein endothelial cells. Cell Physiol Biochem. 45:1893–1903. 2018. View Article : Google Scholar : PubMed/NCBI
20	Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV and Saini AK: Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev. 2020:52453082020. View Article : Google Scholar :
21	Kitada M, Ogura Y and Koya D: The protective role of Sirt1 in vascular tissue: Its relationship to vascular aging and atherosclerosis. Aging (Albany NY). 8:2290–2307. 2016. View Article : Google Scholar
22	Zhang MJ, Zhou Y, Chen L, Wang X, Long CY, Pi Y, Gao CY, Li JC and Zhang LL: SIRT1 improves VSMC functions in atherosclerosis. Prog Biophys Mol Biol. 121:11–15. 2016. View Article : Google Scholar : PubMed/NCBI
23	Stein S and Matter CM: Protective roles of SIRT1 in atherosclerosis. Cell Cycle. 10:640–647. 2011. View Article : Google Scholar
24	Lazaro I, Lopez-Sanz L, Bernal S, Oguiza A, Recio C, Melgar A, Jimenez-Castilla L, Egido J, Madrigal-Matute J and Gomez-Guerrero C: Nrf2 activation provides atheroprotection in diabetic mice through concerted upregulation of antioxidant, anti-inflammatory, and autophagy mechanisms. Front Pharmacol. 9:8192018. View Article : Google Scholar : PubMed/NCBI
25	Mimura J and Itoh K: Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic Biol Med. 88:221–232. 2015. View Article : Google Scholar
26	Gao Z, Sui J, Fan R, Qu W, Dong X and Sun D: Emodin protects against acute pancreatitis-associated lung injury by inhibiting NLPR3 inflammasome activation via Nrf2/HO-1 signaling. Drug Des Devel Ther. 14:1971–1982. 2020. View Article : Google Scholar :
27	Hou Y, Wang Y, He Q, Li L, Xie H, Zhao Y and Zhao J: Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury. Behav Brain Res. 336:32–39. 2018. View Article : Google Scholar
28	Xu H, Chen GF, Ma YS, Zhang HW, Zhou Y, Liu GH, Chen DY, Ping J, Liu YH, Mou X and Fu D: Hepatic proteomic changes and Sirt1/AMPK signaling activation by oxymatrine treatment in rats with non-alcoholic steatosis. Front Pharmacol. 11:2162020. View Article : Google Scholar : PubMed/NCBI
29	Zhou S, Qiao B, Chu X and Kong Q: Oxymatrine attenuates cognitive deficits through SIRT1-mediated autophagy in ischemic stroke. J Neuroimmunol. 323:136–142. 2018. View Article : Google Scholar : PubMed/NCBI
30	Zhu Z, Li J and Zhang X: Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway. BMC Complement Altern Med. 19:1112019. View Article : Google Scholar :
31	Edlich F: BCL-2 proteins and apoptosis: Recent insights and unknowns. Biochem Biophys Res Commun. 500:26–34. 2018. View Article : Google Scholar
32	Grebe A, Hoss F and Latz E: NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res. 122:1722–1740. 2018. View Article : Google Scholar : PubMed/NCBI
33	Esteban-Fernández de Ávila B, Ramírez-Herrera DE, Campuzano S, Angsantikul P, Zhang L and Wang J: Nanomotor-enabled pH-responsive intracellular delivery of caspase-3: Toward rapid cell apoptosis. CS Nano. 11:5367–5374. 2017.
34	Dubois-Deruy E, Peugnet V, Turkieh A and Pinet F: Oxidative stress in cardiovascular diseases. Antioxidants (Basel). 9:8642020. View Article : Google Scholar
35	Li Y, Wang P, Yang X, Wang W, Zhang J, He Y, Zhang W, Jing T, Wang B and Lin R: SIRT1 inhibits inflammatory response partly through regulation of NLRP3 inflammasome in vascular endothelial cells. Mol Immunol. 77:148–156. 2016. View Article : Google Scholar : PubMed/NCBI
36	Falk E: Pathogenesis of atherosclerosis. J Am Coll Cardiol. 47(Suppl 8): C7–C12. 2006. View Article : Google Scholar
37	Lan X, Zhao J, Zhang Y, Chen Y, Liu Y and Xu F: Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. Pharmacol Res. 151:1045412020. View Article : Google Scholar
38	King KL and Cidlowski JA: Cell cycle regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998. View Article : Google Scholar : PubMed/NCBI
39	Bäck M, Yurdagul A Jr, Tabas I, Öörni K and Kovanen PT: Inflammation and its resolution in atherosclerosis: Mediators and therapeutic opportunities. Nat Rev Cardiol. 16:389–406. 2019.PubMed/NCBI
40	Nasonov EL and Popkova TV: Atherosclerosis: Perspectives of anti-inflammatory therapy. Ter Arkh. 90:4–12. 2018.
41	Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A and Mirzaei H: NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J Cell Physiol. 233:2116–2132. 2018. View Article : Google Scholar
42	Dong P, Ji X, Han W and Han H: Oxymatrine exhibits anti-neuroinflammatory effects on Aβ₁₄₂-induced primary microglia cells by inhibiting NF-κB and MAPK signaling pathways. Int Immunopharmacol. 74:1056862019. View Article : Google Scholar
43	Jiang Y, Sang W, Wang C, Lu H, Zhang T, Wang Z, Liu Y, Xue B, Xue S, Cai Z, et al: Oxymatrine exerts protective effects on osteoarthritis via modulating chondrocyte homoeostasis and suppressing osteoclastogenesis. J Cell Mol Med. 22:3941–3954. 2018. View Article : Google Scholar :
44	Bellezza I, Giambanco I, Minelli A and Donato R: Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 1865:721–733. 2018. View Article : Google Scholar : PubMed/NCBI
45	Chen QM and Maltagliati AJ: Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics. 50:77–97. 2018. View Article : Google Scholar :
46	Chen XJ, Wu WJ, Zhou Q, Jie JP, Chen X, Wang F and Gong XH: Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions. J Cell Biochem. Oct 15–2018.Epub ahead of print. View Article : Google Scholar
47	Zhang B, Zhai M, Li B, Liu Z, Li K, Jiang L, Zhang M, Yi W, Yang J, Yi D, et al: Honokiol ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through activating the SIRT1-Nrf2 signaling pathway. Oxid Med Cell Longev. 2018:31598012018.
48	Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K and Genc S: Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway. Front Immunol. 10:15112019. View Article : Google Scholar :
49	Yin Y, Wu X, Peng B, Zou H, Li S, Wang J and Cao J: Curcumin improves necrotising microscopic colitis and cell pyroptosis by activating SIRT1/NRF2 and inhibiting the TLR4 signalling pathway in newborn rats. Innate Immun. 26:609–617. 2020. View Article : Google Scholar
50	Zhang S, Jiang L, Che F, Lu Y, Xie Z and Wang H: Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome. Biochem Biophys Res Commun. 493:821–826. 2017. View Article : Google Scholar : PubMed/NCBI